2023
DOI: 10.1080/10408398.2023.2197066
|View full text |Cite
|
Sign up to set email alerts
|

Emerging pre-clinical safety assessments for potential probiotic strains: a review

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1

Citation Types

0
2
0

Year Published

2023
2023
2025
2025

Publication Types

Select...
7

Relationship

0
7

Authors

Journals

citations
Cited by 12 publications
(2 citation statements)
references
References 212 publications
0
2
0
Order By: Relevance
“…as a novel probiotic antimicrobial lipopeptide-producing bacterium [ 25 ]. Hemolysis is responsible for the destruction of host cells, and screening bacteria for these products is critical for ensuring the safety of a single isolate [ 26 ]. PM5 had a negative hemolytic response, indicating that it is more likely to be a safe isolate with no risk on the host and appropriate for use as probiotics.…”
Section: Discussionmentioning
confidence: 99%
“…as a novel probiotic antimicrobial lipopeptide-producing bacterium [ 25 ]. Hemolysis is responsible for the destruction of host cells, and screening bacteria for these products is critical for ensuring the safety of a single isolate [ 26 ]. PM5 had a negative hemolytic response, indicating that it is more likely to be a safe isolate with no risk on the host and appropriate for use as probiotics.…”
Section: Discussionmentioning
confidence: 99%
“…Additionally, evaluating antibiotic sensitivity, adherence to host tissues, and hemolysis assays, along with conducting animal experimental models, can help determine safety. These methods are commonly used to assess strain safety [ 53 , 54 ]. Moreover, some researchers have assessed strain safety at the genetic level.…”
Section: Screening and Evaluation Of The Potential Strainsmentioning
confidence: 99%